C.V.
Peter Dewland
BSc, MA, MBBS, FFPM, DCPSA
Medical Director
D.O.B: 13th August 1947
11 Church Land
Llanyre
Llandrindod Wells
Powys
LD1 6DX
Tel: +44 (0)1597 823730
Mob: +44 (0)7525 354 521
E-mail:
http://www.peterdewlandconsulting.com
Peter Dewland
BSc, MA, MBBS, FFPM, DCPSA
Medical Director
D.O.B: 13th August 1947
11 Church Land
Llanyre
Llandrindod Wells
Powys
LD1 6DX
Tel: +44 (0)1597 823730
Mob: +44 (0)7525 354 521
E-mail:
I joined the embryonic Phase I CRO industry nearly 30 years ago and my career has grown and matured much in the way which that particular business has grown. I have also worked for a large Global CRO in later phases of drug development. I have been involved in almost every potential therapeutic area over the years and, in particular, have experienced all facets of the drug development progress.
The list is not exhaustive but I have worked recently with drugs from all these therapeutic areas:-
I have supervised extensive trials on just about every possible treatment and pharmacological category for the treatment of asthma. I have completed a programme of studies in Phase I, II & III with a potential anti-asthmatic/anti-allergic drug up to the point of preparing the MAA. I have directed a complete development programme for an antibiotic. I have been involved in many different oncology projects. I was involved in the development of the 5HT3 antagonists for their anti-emetic activity; in so doing I came to work with several oncologists, with whom I still have a good relationship.
Having a background in Clinical Pharmacology has put me in a good position to work in many therapeutic areas. My publication list includes work in the field of rheumatology and, latterly I have been involved in the researching of biologicals and DMARDs in this area.
All aspects of clinical research are understood including the statistical and pharmacokinetic theory behind the trials as well as extensive experience of many disease models/surrogate markers and technology for measuring same.
I am experienced in working with Japanese companies, having been visiting that country for more than twenty years and have cooperated with seven of the top ten major companies for two of which I have directed their full European development programmes. I was in charge of Business Development with Japanese Pharma for a large Global CRO and grew that part of the business from $1million to over $40million a year; in the seven years I was there I brought in $200million of work from Japan. I pride myself in having become familiar with the way these companies work and having grown to understand the culture of the Japanese and their pharmaceutical industry’s approach to R & D.
In my last posts I have managed departments of varying sizes, from responsibility for all the clinical aspects of a large Phase I unit to managing a Medical Affairs group consisting of Medical, Safety, Regulatory and Writing groups. More recently I was in administrative charge of a large UK office of 130 people.
I successfully built up, where none existed before, a Medical Affairs Department providing consultancy and safety services in a CRO setting; in just two years this group was earning over half a million pounds per annum for the company.
During the mid eighties I became very interested in Medical Ethics and, in particular the workings of Research Ethics Committees. I enrolled on a part time Masters course and gained my degree in Medical Ethics having written a dissertation entitled "Research Ethics Committees". I was instrumental in founding, organising and running the first ever Annual Training Conference for members of Ethics committees in the UK, in conjunction with the Department of Philosophy and Health Care at the University of Wales. The group of us who were involved have changed Government thinking and policy in this area and this continuing annual conference has become the forum through which the Department of Health make known any new information on Research Ethics and has introduced its many recent texts on the matter.
As the Faculty of Pharmaceutical Medicine has evolved, I have supported this professional development and contributed as an Educational Supervisor for students undertaking their Pharmaceutical Medicine Specialty Training (PMST). I have also been involved in the Delphi exercise to plan and delineate the training syllabus for the Membership qualifications. In addition I am a member of the Examination Board for the new Diploma in Human Pharmacology.
I have been actively involved in training students for the Diploma in Clinical Pharmacology at the Society of Apothecaries (DCPSA) and formed part of the teaching faculty for this examination. This has been superseded by the Diploma in Human Pharmacology to be set by the Faculty of Pharmaceutical Medicine and I am a member of the Examination Board for this qualification which, it is hoped, will become the standard for Phase I Principal Investigators
I am actively involved in teaching for the Diploma and Master of Clinical Science courses at the University of Wales and have helped assemble examination questions for these qualifications as well as supervising students during the writing of their dissertations.
I am a certified Educational Supervisor at the Royal College of Physicians and act as Educational Supervisor to a cohort of young scientists and physicians training for Pharmaceutical Medicine, Clinical Pharmacology and Clinical Science
Rugby, as a spectator sport, supporting my two sons who play at county and regional levels.
Flying Radio controlled model aircraft.
Touring on my motorcycle.